endocrinology
Type 2 diabetes

7 practice points for peri-operative SGLT2 inhibitor use

The Australian Diabetes Society has issued an alert on the risks of diabetic ketoacidosis (DKA) in people taking SGLT2 inhibitors during the peri-operative period. The alert follows reports of patients with type 2 diabetes developing severe acidosis with the drugs during the peri-operative period, particular if they had been fasting or were dehydrated. Unusually, DKA ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic